Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does not directly cause increased urination as a recognised side effect, but some people starting treatment do notice changes in how often they use the bathroom. Dehydration from nausea or vomiting, shifts in fluid intake, and early blood-sugar changes can all play a role — and it's worth understanding which is which. These are prescription-only medicines, and any persistent or unusual urinary symptoms should be discussed with a prescriber rather than written off as an expected part of treatment. Below, we cover what the clinical evidence actually shows, what to watch for, and when a symptom crosses the line from unremarkable to worth acting on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no. According to the NHS medicines page for semaglutide, the recognised common side effects centre on the gut: nausea, vomiting, diarrhoea, constipation, stomach discomfort, reflux, and fatigue. Urinary frequency does not appear in the common or uncommon category of the approved UK Summary of Product Characteristics for Wegovy.
That doesn't mean nobody notices urinary changes. It means the changes people experience are typically downstream of something else, gastrointestinal side effects reducing how much fluid the body takes in, or (for those who also have type 2 diabetes) the indirect effect of better blood-glucose control on how the kidneys filter fluid. Both are worth knowing about, and neither is a reason to stop treatment without speaking to a prescriber first.
If you want a deeper look at whether semaglutide specifically increases urinary output, the full clinical breakdown covers that question in detail. For now, the headline: increased urination is not a direct pharmacological effect the trial programmes expected or observed as a primary signal.
This is the connection most people don't make, and it matters. Semaglutide slows gastric emptying and reduces appetite, that's the mechanism behind the weight loss. But for many people, particularly in the first few weeks or after a dose increase, it also brings nausea and sometimes vomiting. When that happens, fluid intake often drops, and dehydration follows quietly.
Reduced fluid going in means reduced urine coming out, and what does come out may be darker and more concentrated. That's not a direct drug effect on the kidneys; it's basic physiology. The fix (drinking enough water throughout the day, especially if you're nauseous and not eating much) is simple in theory but easy to forget when you feel rough.
The flipside can also happen. Some people consciously drink more water on treatment, either because they've been advised to or because thirst feels different. More fluid in, more urine out. Neither pattern is alarming on its own. What would be alarming is significant reduction in urination alongside dizziness, rapid heartbeat, or confusion, signs of meaningful dehydration that need prompt medical attention. The NHS England guidance on weight management injections specifically flags dehydration risk when vomiting is prolonged, and it's a reason to contact your prescriber rather than push through.
You can read more about semaglutide treatment and how it works on our semaglutide overview page, and if you are also prescribed a biologic such as Cosentyx, our guide on whether you can take Wegovy and Cosentyx together explains what to discuss with your prescriber.
Urinary tract infections are common in the general population (roughly one in two women will have at least one in their lifetime) so it's not surprising they come up in the context of GLP-1 treatment. But are people on semaglutide at higher risk?
The clinical trial data doesn't single out semaglutide as a driver of UTI risk. However, if someone has uncontrolled or newly-diagnosed diabetes, elevated blood glucose creates an environment where bacteria thrive in the urinary tract. As semaglutide stabilises glucose levels over time, that risk can actually decrease. That said, a UTI is a UTI regardless of cause, and the symptoms (burning when passing urine, needing to go urgently and often, cloudy or strong-smelling urine, pelvic pain) all need assessment.
Our page on semaglutide and urinary tract infections goes into more detail on this specifically. The practical point: don't assume a UTI is part of semaglutide's side-effect profile and leave it untreated. A short course of antibiotics, usually arranged quickly through a GP or pharmacy, resolves most uncomplicated cases. Blood in the urine or a fever alongside urinary symptoms warrants same-day contact with a clinician.
If you're already on treatment and want to check something with our team, you can reach us through the contact page, we offer 7-day aftercare as standard.
Most urinary changes noticed on semaglutide are benign and transient. A few are not. Here's a plain guide to the difference.
Contact a clinician the same day if you notice: blood in your urine; burning or pain on urination combined with fever or back/flank pain (which can signal a kidney infection rather than a bladder infection); a sudden, significant drop in urine output over several hours, especially alongside vomiting; or swelling of the ankles and legs combined with reduced urination, which can be a sign of kidney stress.
Call 999 or go to A&E if urinary symptoms come alongside confusion, severe weakness, or signs of a serious allergic reaction (swelling of the throat or face, difficulty breathing). These combinations are rare but need immediate assessment.
For side effects that concern you but aren't emergencies, the MHRA's Yellow Card scheme lets you report suspected reactions directly, this reporting genuinely helps regulators build a better picture of how medicines behave in the real world. It's open to patients, not just healthcare professionals. If you're curious about Wegovy more broadly (how it works, what to expect, and who it's suitable for) our Wegovy treatment page is a good place to start, and you can find a detailed look at dosing and administration on our semaglutide 1 mg page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.